These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17302032)

  • 1. [Differences in the risk factors for clinical benign prostatic hyperplasia between the Mongolian and the Han people].
    Wang YB; Xie LP; Yuan YG; Zheng XY; Qin J
    Zhonghua Nan Ke Xue; 2007 Jan; 13(1):33-6. PubMed ID: 17302032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the lifestyle of Mongolian pastoralists in China in connection with urbanization.
    Fu J; Takano T; Nakamura K; Yang JF; Watanabe M
    J Med Dent Sci; 2000 Jun; 47(2):123-32. PubMed ID: 12160184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Goodman P; Penson DF; Thompson IM
    Am J Epidemiol; 2008 Apr; 167(8):925-34. PubMed ID: 18263602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia.
    Platz EA; Rimm EB; Kawachi I; Colditz GA; Stampfer MJ; Willett WC; Giovannucci E
    Am J Epidemiol; 1999 Jan; 149(2):106-15. PubMed ID: 9921955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case-control study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang].
    Ning X; Shi JP; Wu ZY; Zheng LG; Wang HL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):276-80. PubMed ID: 12820944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic differences in overweight and obesity between Han and Mongolian rural Chinese.
    Zhang X; Sun Z; Zheng L; Liu S; Xu C; Li J; Li J; Hu D; Sun Y
    Acta Cardiol; 2009 Apr; 64(2):239-45. PubMed ID: 19476118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake.
    Gass R
    BJU Int; 2002 Nov; 90(7):649-54. PubMed ID: 12410741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Composition and histopathological features of prostatic calculi in patients with benign prostatic hyperplasia].
    Jin YS; Dong B; Jia JQ; Wang F; He XL; Gao JX; Li Y
    Zhonghua Nan Ke Xue; 2021 Sep; 27(9):809-814. PubMed ID: 34914257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.
    Meigs JB; Mohr B; Barry MJ; Collins MM; McKinlay JB
    J Clin Epidemiol; 2001 Sep; 54(9):935-44. PubMed ID: 11520654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of gastroesophageal reflux disease in Uygur and Han Chinese adults in Urumqi.
    Niu CY; Zhou YL; Yan R; Mu NL; Gao BH; Wu FX; Luo JY
    World J Gastroenterol; 2012 Dec; 18(48):7333-40. PubMed ID: 23326142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas.
    Yue L; Wang T; Ge Y; Ge M; Zhang C; Hou Q; Wang W; Tian H; Ren B; Du B; Zhang W
    Prostate; 2019 Feb; 79(3):312-319. PubMed ID: 30450670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men.
    Zlotta AR; Egawa S; Pushkar D; Govorov A; Kimura T; Kido M; Takahashi H; Kuk C; Kovylina M; Aldaoud N; Fleshner N; Finelli A; Klotz L; Lockwood G; Sykes J; Kwast Tv
    Eur Urol; 2014 Oct; 66(4):619-22. PubMed ID: 25012523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impacts of metabolic syndrome and lifestyle on the prevalence of benign prostatic hyperplasia requiring treatment: historical cohort study of 130 454 men.
    Yoo S; Oh S; Park J; Cho SY; Cho MC; Jeong H; Son H
    BJU Int; 2019 Jan; 123(1):140-148. PubMed ID: 30125452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: A randomized controlled trial.
    Zendehdel A; Ansari M; Khatami F; Mansoursamaei S; Dialameh H
    Clin Nutr; 2021 May; 40(5):3325-3331. PubMed ID: 33213976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart(®) ) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment-naïve men with moderately symptomatic benign prostatic hyperplasia: 2-year CONDUCT study results.
    Roehrborn CG; Oyarzabal Perez I; Roos EP; Calomfirescu N; Brotherton B; Wang F; Palacios JM; Vasylyev A; Manyak MJ
    BJU Int; 2015 Sep; 116(3):450-9. PubMed ID: 25565364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.